BLLN Stock: Price, Earnings History and SEC Filings
BillionToOne, Inc. (BLLN) last traded at $113.32, down 1.32% on the latest session and up 6.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.15 against an analyst estimate of $0.15, a beat of 0.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BLLN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.15 | $0.15 | +0.00% |
| Mar 2026 | May 6, 2026 | $0.34 | $0.01 | +3300.00% |
| Dec 2025 | Mar 4, 2026 | $0.11 | $0.07 | +57.14% |
| Sep 2025 | Dec 9, 2025 | $0.10 | $0.16 | -37.50% |
BLLN beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How BLLN reacts to earnings
Across its last 5 earnings releases, BLLN moved 16.9% on average the next session, in either direction. It rose after 2 of 5 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-05 | After close | -38.89% |
| 2026-05-06 | After close | +14.13% |
| 2026-03-04 | After close | -10.71% |
| 2026-01-12 | Before open | +15.37% |
| 2025-12-09 | After close | -5.32% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
BLLN financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $305M | $7M | $16M | 2.4% | $0.14 |
| 2024 | $153M | -$42M | -$47M | -27.2% | $-4.12 |
| 2023 | $72M | -$83M | -$60M | -115.3% | $-8.45 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BLLN
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 29, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · Jun 16, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 10-Q · May 6, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 21, 2026
- 10-K · Mar 11, 2026
- 8-K · Mar 4, 2026Results of operations, Officer or director change, Financial statements and exhibits
- 8-K · Jan 12, 2026Results of operations, Regulation FD disclosure
Insider filing activity
BLLN insiders filed 27 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
BLLN news
- BillionToOne: New Kid On The Molecular Diagnostics Block Poised To Take ShareOct 29, 2026 · seekingalpha.com
- Baxter International (BAX) Q3 Earnings and Revenues Surpass EstimatesOct 29, 2026 · finance.yahoo.com
- Top Specialty Lab Stocks to Watch This Earnings Season, According to BTIGOct 29, 2026 · finance.yahoo.com
- BillionToOne (BLLN) Reports Next Week: Wall Street Expects Earnings GrowthOct 28, 2026 · finance.yahoo.com
- BillionToOne to Participate in Two Upcoming Investor ConferencesOct 27, 2026 · finance.yahoo.com
About BillionToOne, Inc.
BillionToOne, Inc. (BLLN) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-medical Laboratories. It is incorporated in DE. Its fiscal year ends in December.